The phrase "and specificity in identifying" is correct and usable in written English.
It can be used when discussing the importance of being precise or detailed in the process of identification, such as in research or analysis contexts.
Example: "The study emphasizes the need for clarity and specificity in identifying the variables that influence the outcome."
Alternatives: "and precision in recognizing" or "and accuracy in determining".
One of the weaknesses of syndromic surveillance is its lack of sensitivity and specificity in identifying specific diseases.
Sensitivity and specificity in identifying T2d were quite variable across the phenotypes.
The novel platform is based on real-time PCR-SSP, and performs with high sensitivity and specificity in identifying carriers of the 49 most common class I HLA-A, -B, and -C alleles in East Africa, providing 80 90% population coverage.
In addition, the recognition of risk factors had limited sensitivity and specificity in identifying those individuals infected by oocysts.
We included those studies in which the predictive value had been assessed by calculating both sensitivity and specificity in identifying those patients who subsequently responded to fluid challenge.
42 When correlated with Gleason score, MRI has been shown to have good sensitivity and specificity in identifying tumors with more aggressive disease.
NRS-2002 had been shown to have a high sensitivity (62%) and specificity (93%) in identifying malnutrition, and its score predicts clinical outcomes.
In analysis of the National Health and Nutrition Examination Survey data, Buell et al. (9) reported that an A1C level of 5.8% showed the highest sensitivity (86%) and specificity (92%) in identifying undiagnosed diabetes when using FPG concentration as the diagnostic test for type 2 diabetes.
The classifications on the test-set were near perfect with one outlier of 23 samples, reaching 100% accuracy in identifying non-brain primary tumors from brain primary tumors, and 88% sensitivity with 100% specificity in identifying metastatic brain tumors from brain primary tumors, for both C RT* and C RT (Table S2).
J591 has been extensively utilized and evaluated in different preclinical models, demonstrating higher specificity in identifying tumor tissue [ 38].
The specific co-morbidity measure should be chosen based on conditions necessary for that particular study, the acceptable or desirable degree of sensitivity or specificity in identifying these co-morbidities, and with the understanding of limitations involved with each of the specific measures.
